← All Incordex CORP filings

Incordex CORP 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

OTC.Pink
ICDX
Incordex CORP
10-Q: Incordex Corp. Reports Q3 Loss, Zero Assets Amid Leadership Change
Incordex Corp. reported a net loss for the quarter, zero total assets, and a significant decline in revenue, alongside a change in executive leadership.
OTC.Pink
ICDX
Incordex CORP
10-Q: Incordex Corp. Faces Going Concern Doubts Amidst Revenue Drop
Incordex Corp. reported increased net income for Q2 2025 driven by debt forgiveness, despite a significant revenue decline and ongoing going concern doubts.
OTC.Pink
ICDX
Incordex CORP
10-Q: Incordex Corp. Reports Net Income of $5,098 for Quarter Ended September 30, 2024, Despite Going Concern Concerns
Incordex Corp. reported a net income of $5,098 for the quarter ending September 30, 2024, a significant improvement from the same period last year, but faces substantial doubt about its ability to continue as a going concern.
OTC.Pink
ICDX
Incordex CORP
10-Q: Incordex Corp. Reports First Revenue and Positive Net Income in Q3 2024
Incordex Corp. reports its first revenue and a net profit for the quarter ending March 31, 2024, driven by the launch of a new website and mobile application.
OTC.Pink
ICDX
Incordex CORP
10-Q: Incordex Corp. Reports First Revenue in Latest Quarterly Filing, But Going Concern Doubts Remain
Incordex Corp. reports its first revenue in the latest quarter, but the company's ability to continue as a going concern remains in doubt.